What is the management of Rhabdomyolysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Rhabdomyolysis

Immediately initiate aggressive intravenous fluid resuscitation with isotonic saline targeting a urine output of 300 mL/hour to prevent acute kidney injury, which is the most critical intervention in rhabdomyolysis management. 1

Immediate Fluid Resuscitation

Aggressive IV fluid administration is the cornerstone of treatment and must be started without delay. 1 Early initiation is critical, as delayed treatment significantly increases the risk of acute kidney injury. 2, 1

  • For severe rhabdomyolysis (CK >15,000 IU/L): Administer more than 6L of fluid per day 2, 1
  • For moderate cases: Administer 3-6L per day 2, 1
  • Target urine output: Maintain at least 300 mL/hour to facilitate myoglobin clearance and prevent renal tubular obstruction 1, 3
  • Monitor closely for fluid overload, particularly in patients with cardiac or renal compromise 1

The large volume requirements reflect the need to rapidly clear myoglobin from the circulation before it causes tubular obstruction and acute tubular necrosis. 3, 4

Discontinue All Causative Agents Immediately

Stop all medications and supplements that may have contributed to rhabdomyolysis as soon as the diagnosis is suspected. 2, 1

  • Statins and other prescription medications must be discontinued immediately 2, 1
  • Dietary supplements to discontinue: red yeast rice (containing lovastatin), creatine monohydrate, wormwood oil, licorice, and Hydroxycut 2, 1
  • In anesthesia settings: Avoid succinylcholine and inhaled anesthetics in at-risk populations 1

Electrolyte Monitoring and Correction

Check electrolyte panels every 6-12 hours in severe cases, with particular attention to potassium levels. 1

  • Repeated bioassessment should include: plasma myoglobin, CK, and potassium measurements 2
  • Correct significant hyperkalemia immediately, as it can precipitate cardiac arrhythmias and arrest 1
  • Monitor and correct: hypocalcemia and hyperphosphatemia 1
  • Assess for metabolic acidosis via arterial blood gas, which commonly occurs in severe cases 2, 1

Hyperkalemia is particularly dangerous as it can lead to life-threatening cardiac complications including pulseless electrical activity and cardiac arrest. 1

Compartment Syndrome Surveillance

Maintain high suspicion for compartment syndrome, which can both cause and complicate rhabdomyolysis. 2, 1

  • Early signs to monitor: pain, tension, paresthesia, and paresis 2, 1
  • Late signs indicating irreversible damage: pulselessness and pallor 2, 1
  • Perform early fasciotomy when:
    • Compartment pressure exceeds 30 mmHg, OR
    • Differential pressure (diastolic blood pressure – compartment pressure) is <30 mmHg 2, 1

Missing compartment syndrome in traumatic or severe exertional cases can lead to irreversible muscle and nerve damage. 1

Pain Management Algorithm

Use acetaminophen as first-line analgesic at 500-1000 mg (maximum 4-6 grams daily) to avoid nephrotoxic effects. 2, 1

  • Avoid all NSAIDs (ibuprofen, ketoprofen, diclofenac, naproxen, mefenamic acid) due to gastrointestinal and renal toxicity 2, 1
  • For severe pain unresponsive to acetaminophen:
    • Use oral morphine 20-40 mg for opioid-naive patients 2, 1
    • Provide round-the-clock dosing with rescue doses (10-15% of total daily dose) for breakthrough pain 2
  • In patients with established acute kidney injury (eGFR <30 mL/min):
    • Use fentanyl or buprenorphine as safest opioid choices 2, 1

Renal Replacement Therapy Indications

Consider renal replacement therapy for specific complications that cannot be managed medically. 1

  • Indications for RRT:
    • Refractory hyperkalemia
    • Severe metabolic acidosis
    • Progressive acute kidney injury despite adequate hydration 1
  • Initiate RRT if: CK remains persistently elevated despite 4 days of adequate hydration 1
  • Consider discontinuation when: urine output recovers adequately (>100 mL/day) 1

Duration of IV Fluid Therapy

Continue intravenous fluids until CK levels decrease to less than 1,000 U/L. 3

This endpoint indicates that active muscle breakdown has ceased and the risk of ongoing myoglobin-induced renal injury has substantially decreased. 3, 4

Critical Pitfalls to Avoid

  • Do not delay fluid resuscitation, as this is associated with higher risk of acute kidney injury and worse outcomes 1
  • Do not use inadequate fluid volumes, which may fail to prevent renal complications 1
  • Do not miss compartment syndrome, particularly in traumatic or severe exertional cases 1
  • Do not use NSAIDs for pain management due to nephrotoxic effects in patients already at high risk for acute kidney injury 2, 1

Special Considerations for Statin-Induced Cases

For statin-associated rhabdomyolysis, consider nonstatin therapies for continued lipid management after discontinuation. 2

  • Alternative lipid-lowering agents: ezetimibe, PCSK9 inhibitors, or bempedoic acid 2
  • If statins are eventually needed: use hydrophilic statins (fluvastatin, pravastatin) as they have fewer metabolic interactions 2
  • Genetic risk factors: SLCO1B1 gene mutations increase risk of statin-induced rhabdomyolysis 2

References

Guideline

Management of Rhabdomyolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rhabdomyolysis Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rhabdomyolysis: review of the literature.

Neuromuscular disorders : NMD, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.